MarketBeat
08 Jun 2026, 11:40 UTC · 3h ago
3 Longevity ETFs to Buy and Hold (and Hold)
MarketBeat
08 Jun 2026, 11:40 UTC · 3h ago
Story key points
3 claims · impact-rated
The longevity industry is projected to nearly triple in size between 2025 and 2035. — A projected 3x growth in a sector's total addressable market is a strong long-term bullish signal for related biotech and healthcare equities.
+0.60Longevity-focused and healthcare innovation ETFs, including BMED and AGNG, have significantly underperformed the broader market in 2026. — Recent underperformance indicates a short-term lack of investor appetite or failure of thematic catalysts to materialize in the current year.
-0.30The Global X Aging Population ETF (AGNG) has low trading volumes and a small asset base of $81 million, creating liquidity risks for investors. — Low liquidity increases slippage and execution risk, making the asset less attractive for institutional or large-scale investors.
-0.20Ticker attribution
Continue reading
6 related stories
Top 2 movers · tap to explore
Model heads
The fund's managers have significantly underperformed the market so far in 2026.
Strong 12-month returns of over 50% offset by sluggish YTD performance and a 'Hold' rating from analysts.
The strategy has not yet paid off in 2026 returns and the fund suffers from low liquidity.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
7 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Schaeffers Research
1h ago
